NCOR1 and acute myeloid leukemia: Identification and characterization of misfolded N-CoR protein as a molecular target and as a subtype specific biomarker of AML will facilitate better understanding of the molecular mechanisms underlying AML pathogenesis and will provide a common diagnostic and therapeutic target across all promyelocytic and monocytic AML variants.